175 related articles for article (PubMed ID: 27233931)
21. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
[TBL] [Abstract][Full Text] [Related]
22. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
23. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
24. Endoscopic Approaches to Upper Tract Urothelial Carcinoma.
Petros FG; Li R; Matin SF
Urol Clin North Am; 2018 May; 45(2):267-286. PubMed ID: 29650142
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Segura JW; Zincke H; Elliott DS; Blute ML
J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
[TBL] [Abstract][Full Text] [Related]
26. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
27. Imperative indications for conservative management of upper tract transitional cell carcinoma.
Krambeck AE; Thompson RH; Lohse CM; Patterson DE; Elliott DS; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma.
Gadzinski AJ; Roberts WW; Faerber GJ; Wolf JS
J Urol; 2010 Jun; 183(6):2148-53. PubMed ID: 20399468
[TBL] [Abstract][Full Text] [Related]
29. Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.
Gandaglia G; Bianchi M; Trinh QD; Becker A; Larouche A; Abdollah F; Roghmann F; Tian Z; Shariat SF; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Int J Urol; 2014 Mar; 21(3):249-56. PubMed ID: 24033809
[TBL] [Abstract][Full Text] [Related]
30. Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management.
Mohapatra A; Strope SA; Liu N; Winer A; Benfante NE; Coleman JA; Vetter J; Murray KS
Int Urol Nephrol; 2020 Aug; 52(8):1465-1469. PubMed ID: 32157621
[TBL] [Abstract][Full Text] [Related]
31. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
32. Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.
Villa L; Cloutier J; Letendre J; Ploumidis A; Salonia A; Cornu JN; Montorsi F; Traxer O
World J Urol; 2016 Sep; 34(9):1201-6. PubMed ID: 26699629
[TBL] [Abstract][Full Text] [Related]
33. Predictors of survival in patients with disease recurrence after radical nephroureterectomy.
Kluth LA; Xylinas E; Kent M; Hagiwara M; Kikuchi E; Ikeda M; Matsumoto K; Dalpiaz O; Zigeuner R; Aziz A; Fritsche HM; Deliere A; Raman JD; Bensalah K; Al-Matar B; Gakis G; Novara G; Klatte T; Remzi M; Comploj E; Pycha A; Rouprêt M; Tagawa ST; Chun FK; Scherr DS; Vickers AJ; Shariat SF
BJU Int; 2014 Jun; 113(6):911-7. PubMed ID: 24053651
[TBL] [Abstract][Full Text] [Related]
34. Postoperative and Survival Outcomes After Cytoreductive Surgery in the Treatment of Metastatic Upper Tract Urothelial Carcinoma.
Pollock G; Hsu CH; Batai K; Lee BR; Chipollini J
Urology; 2021 Jul; 153():244-249. PubMed ID: 33482133
[TBL] [Abstract][Full Text] [Related]
35. Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registry.
Soria F; Laguna MP; Roupret M; Garcia-Marchinena P; Gonzalez MS; Habuchi T; Erkan E; Ng A; Gontero P; de la Rosette J
BJU Int; 2021 Dec; 128(6):734-743. PubMed ID: 34028166
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
Bagrodia A; Kuehhas FE; Gayed BA; Wood CG; Raman JD; Kapur P; Derweesh IH; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
[TBL] [Abstract][Full Text] [Related]
37. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.
Smith AK; Stephenson AJ; Lane BR; Larson BT; Thomas AA; Gong MC; Jones JS; Campbell SC; Hansel DE
Urology; 2011 Jul; 78(1):82-6. PubMed ID: 21550642
[TBL] [Abstract][Full Text] [Related]
38. [Conservative management of urothelial carcinomas of the upper urinary tract].
Rouprêt M
Prog Urol; 2012 Nov; 22(14):861-6. PubMed ID: 23101956
[TBL] [Abstract][Full Text] [Related]
39. Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma.
Lee JN; Kwon SY; Choi GS; Kim HT; Kim TH; Kwon TG; Kim BW
J Surg Oncol; 2014 Sep; 110(4):468-75. PubMed ID: 25059848
[TBL] [Abstract][Full Text] [Related]
40. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
